These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 22462566)

  • 1. Role of transrectal ultrasonography (TRUS) in focal therapy of prostate cancer: report from a Consensus Panel.
    Smeenge M; Barentsz J; Cosgrove D; de la Rosette J; de Reijke T; Eggener S; Frauscher F; Kovacs G; Matin SF; Mischi M; Pinto P; Rastinehad A; Rouviere O; Salomon G; Polascik T; Walz J; Wijkstra H; Marberger M
    BJU Int; 2012 Oct; 110(7):942-8. PubMed ID: 22462566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of magnetic resonance imaging (MRI) in focal therapy for prostate cancer: recommendations from a consensus panel.
    Muller BG; Fütterer JJ; Gupta RT; Katz A; Kirkham A; Kurhanewicz J; Moul JW; Pinto PA; Rastinehad AR; Robertson C; de la Rosette J; Sanchez-Salas R; Jones JS; Ukimura O; Verma S; Wijkstra H; Marberger M
    BJU Int; 2014 Feb; 113(2):218-27. PubMed ID: 24215670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transrectal ultrasonography-guided biopsy does not reliably identify dominant cancer location in men with low-risk prostate cancer.
    Washington SL; Bonham M; Whitson JM; Cowan JE; Carroll PR
    BJU Int; 2012 Jul; 110(1):50-5. PubMed ID: 22077660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Focal therapy in prostate cancer-report from a consensus panel.
    de la Rosette J; Ahmed H; Barentsz J; Johansen TB; Brausi M; Emberton M; Frauscher F; Greene D; Harisinghani M; Haustermans K; Heidenreich A; Kovacs G; Mason M; Montironi R; Mouraviev V; de Reijke T; Taneja S; Thuroff S; Tombal B; Trachtenberg J; Wijkstra H; Polascik T
    J Endourol; 2010 May; 24(5):775-80. PubMed ID: 20477543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating localized prostate cancer and identifying candidates for focal therapy.
    Sartor AO; Hricak H; Wheeler TM; Coleman J; Penson DF; Carroll PR; Rubin MA; Scardino PT
    Urology; 2008 Dec; 72(6 Suppl):S12-24. PubMed ID: 19095124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colour Doppler and microbubble contrast agent ultrasonography do not improve cancer detection rate in transrectal systematic prostate biopsy sampling.
    Taverna G; Morandi G; Seveso M; Giusti G; Benetti A; Colombo P; Minuti F; Grizzi F; Graziotti P
    BJU Int; 2011 Dec; 108(11):1723-7. PubMed ID: 21756276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transrectal ultrasound (TRUS) and TRUS-biopsy accuracy in potential candidates for PRIAS active surveillance protocol.
    Lacetera V; Galosi AB; Cantoro U; Catanzariti F; Mazzaferro D; Cantoro D; Quaresima L; Conti A; Raquban R; Montironi R; Muzzonigro G
    Arch Ital Urol Androl; 2012 Dec; 84(4):272-5. PubMed ID: 23427762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transperineal 3D mapping biopsy of the prostate: an essential tool in selecting patients for focal prostate cancer therapy.
    Onik G; Barzell W
    Urol Oncol; 2008; 26(5):506-10. PubMed ID: 18774464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Method of the connection HMRS and TRUS images--improvement of effectiveness transrectal core biopsy of the prostate].
    Lipczyński W
    Przegl Lek; 2012; 69(5):176-80. PubMed ID: 23050412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate carcinoma: transrectal US after cryosurgical ablation.
    Salomon CG; Kalbhen CL; Dudiak CM; Olson MC; Flisak ME; Flanigan RC
    Radiology; 1998 Feb; 206(2):533-8. PubMed ID: 9457209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of transrectal ultrasonography in prostate cancer.
    Ghai S; Toi A
    Radiol Clin North Am; 2012 Nov; 50(6):1061-73. PubMed ID: 23122038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities.
    Eggener SE; Scardino PT; Carroll PR; Zelefsky MJ; Sartor O; Hricak H; Wheeler TM; Fine SW; Trachtenberg J; Rubin MA; Ohori M; Kuroiwa K; Rossignol M; Abenhaim L;
    J Urol; 2007 Dec; 178(6):2260-7. PubMed ID: 17936815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classification of focal prostatic lesions on transrectal ultrasound (TRUS) and the accuracy of TRUS to diagnose prostate cancer.
    Lee HY; Lee HJ; Byun SS; Lee SE; Hong SK; Kim SH
    Korean J Radiol; 2009; 10(3):244-51. PubMed ID: 19412512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endorectal magnetic resonance imaging and magnetic resonance spectroscopy to monitor the prostate for residual disease or local cancer recurrence after transrectal high-intensity focused ultrasound.
    Cirillo S; Petracchini M; D'Urso L; Dellamonica P; Illing R; Regge D; Muto G
    BJU Int; 2008 Aug; 102(4):452-8. PubMed ID: 18476973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transrectal ultrasonography for the detection and staging of carcinoma of the prostate.
    Smith JA
    J Clin Ultrasound; 1996 Oct; 24(8):455-61. PubMed ID: 8884522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Image visibility of cancer to enhance targeting precision and spatial mapping biopsy for focal therapy of prostate cancer.
    Ukimura O; de Castro Abreu AL; Gill IS; Shoji S; Hung AJ; Bahn D
    BJU Int; 2013 Jun; 111(8):E354-64. PubMed ID: 23714647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate cancer ablation with transrectal high-intensity focused ultrasound: assessment of tissue destruction with contrast-enhanced US.
    Rouvière O; Glas L; Girouin N; Mège-Lechevallier F; Gelet A; Dantony E; Rabilloud M; Chapelon JY; Lyonnet D
    Radiology; 2011 May; 259(2):583-91. PubMed ID: 21357522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of precise and multimodal MRI and TRUS in detection and management of early prostate cancer.
    Ukimura O
    Expert Rev Med Devices; 2010 Jul; 7(4):541-54. PubMed ID: 20583890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transrectal ultrasound-guided biopsy of prostate voxels identified as suspicious of malignancy on three-dimensional (1)H MR spectroscopic imaging in patients with abnormal digital rectal examination or raised prostate specific antigen level of 4-10 ng/ml.
    Kumar V; Jagannathan NR; Kumar R; Thulkar S; Gupta SD; Hemal AK; Gupta NP
    NMR Biomed; 2007 Feb; 20(1):11-20. PubMed ID: 16894640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Conventional transrectal ultrasound guided biopsy. Current role, indications, techniques and limitations].
    Areal Calama J
    Arch Esp Urol; 2015 Apr; 68(3):282-95. PubMed ID: 25948800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.